Call for revolution: A new approach to describing allograft deterioration

American Journal of Transplantation

Volumn 2, Issue 3, 2002, Pages 195-200

  Halloran, Philip F ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN INHIBITOR;

ALLOIMMUNITY; BRAIN DEATH; DIABETIC NEPHROPATHY; DONOR; GLOMERULOPATHY; GRAFT INFECTION; GRAFT PRESERVATION; GRAFT SURVIVAL; HEMOLYTIC UREMIC SYNDROME; HYPERLIPIDEMIA; HYPERTENSION; IMMUNE MEDIATED INJURY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT REJECTION; KIDNEY DYSFUNCTION; KIDNEY TRANSPLANTATION; POLYURIA; PROTEINURIA; RENOVASCULAR HYPERTENSION; REVIEW; T LYMPHOCYTE;

DISEASE PROGRESSION; GRAFT REJECTION; HUMANS; KIDNEY TRANSPLANTATION; TRANSPLANTATION, HOMOLOGOUS;

EID: 0036523936     PISSN: 16006135     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-6143.2002.20301.x     Document Type: Review

References (47)

1. Kasiske BL, Heim-Duthoy KL, Tortorice KL, Rao KV. The variable nature of chronic declines in renal allograft function. Transplant 1991; 51: 330-334.
2. Hildemann WH, Walford RL. Chronic skin homograft rejection in the Syrian hamster. Ann NY Acad Sci 1960; 87: 56-77.
3. Hume DM, Merrill JP, Miller BF, Thorn GW. Experiences with renal homotransplantation in the human: report of nine cases. J Clin Invest 1955; 34: 327-382.
4. Peart WS, Rendall JM, Starzl TE et al. Human renal transplants. I. Glomerular changes. Lab Invest 1967; 16: 153-181.
5. Jeannet M, Pinn VW, Flax MH, Winn HJ, Russell PS. Humoral antibodies in renal allotransplantation in man. N Engl J Med 1970; 282: 111-117.
6. Williams GM, Lee HM, Weymouth RF et al. Studies in hyperacute and chronic renal homograft rejection in man. Surgery 1967; 62: 204-212.
7. Harlan WR Jr, Holden KR, Williams GM, Hume DM. Proteinuria and nephrotic syndrome associated with chronic rejection of kidney transplants. N Engl J Med 1967; 277: 769-776.
8. Takemoto S, Cho YW. Significance of the donor age effect on kidney transplants. In: Cecka, JM, Terasaki, PI, eds. Clinical Transplants. Los Angeles, CA: UCLA Tissue Typing Laboratory; 1997. pp. 366-372.
9. Libby P, Pober JS. Chronic rejection. Immunity 2001; 14: 387-397.
10. Pirsch JD, Kalayoglu M, Hafez GR, D'Alessandro AM, Sollinger HW, Belzer FD. Evidence that the vanishing bile duct syndrome is vanishing. Transplant 1990; 49: 1015-1018.
11. Yousem SA, Burke CM, Billingham ME. Pathologic pulmonary alterations in long-term human heart-lung transplantation. Hum Pathol 1985; 16: 911-923.
12. Dawkins KD, Jamieson SW, Hunt SA et al. Long-term results, hemodynamics, and complications after combined heart and lung transplantation. Circulation 1985; 71: 919-926.
13. Stewart KC, Patterson GA. Current trends in lung transplantation. Am J Transplant 2001; 1: 204-210.
14. Paul LC. Chronic allograft nephropathy: an update. [Review] [142 refs]. Kidney Int 1999; 56: 783-793.
15. Ponticelli C. Progression of renal damage in chronic rejection. Kidney Int 2000; 57 (Suppl. 75): S62-S70.
16. Halloran PF, Melk A, Barth C. Rethinking chronic allograft nephropathy - the concept of accelerated senescence [review]. J Am Soc Nephrol 1999; 10: 167-181.
17. Ringers J, Rosendaal FR, Claas FH et al. Increased immunogenicity and cause of graft loss of old donor kidneys. J Am Soc Nephrol 2001; 12: 1538-1546.
18. Riera L, Fulladosa X, Ramos R et al. Donor age and delayed graft function as predictors of renal allograft survival in rejection-free patients. Nephrol Dial Transplant 1999; 14: 930-935.
19. Terasaki PI, Cecka JM, Gjertson DW, Takemoto S. High survival rates of kidney transplants from spousal and living unrelated donors. N Engl J Med 1995; 333: 333-336.
20. Halloran PF, Hunsicker LG. Delayed graft function: State of the Art. November 10-11, 2000. Summit Meeting, Scottsdale, Arizona, USA. Am J Transplant 2001; 1: 115-120.
21. Brasile L, Stubenitsky BM, Booster MH, Arenada D, Haisch C, Kootstra G. Hypothermia - a limiting factor in using warm ischemically damaged kidneys. Am J Transplant 2001; 1: 316-320.
22. Hunsicker LG, Bennett LE. Acute rejection reduces creatinine clearance (Ccr) at 6 months following renal transplantation but does not affect subsequent slope of Ccr [abstract]. Transplant 1999; 67: S83.
23. Hunsicker LG, Adler S, Caggiula A et al. Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study. Kidney Int 1997; 51: 1908-1919.
24. Matas AJ, Solez K. From first principles - tubulitis in protocol biopsies and learning from history. Am J Transplant 2001; 1: 4-5.
25. Bartosh SM, Thistlethwaite JR, Woodle ES et al. The relationship of untreated borderline infiltrates by the Banff criteria to acute rejection in renal allograft biopsies. J Am Soc Nephrol 1999; 10: 1806-1814.
26. Giordani C, Riera L, Fulladosa X et al. Serial protocol biopsies to quantify the progression of chronic transplant nephropathy in stable renal allografts. Am J Transplant 2001; 1: 82-88.
27. Solez K, Vincenti F, Filo R. Histopathologic findings from two-year protocol biopsies from a US multicenter kidney transplant trial comparing tacrolimus versus cyclosporine: a report of the FK506 Kidney Transplant Study Group. Transplant 1998; 66: 1736-1740.
28. Iványi B, Fahmy H, Brown H, Szenohradszky P, Halloran PF, Solez K. Peritubular capillaries in chronic renal allograft rejection: a quantitative ultrastructural study. Hum Pathol 2000; 31: 1129-1138.
29. Fogo A. Chronic transplant glomerulopathy. Am J Kidney Dis 2000; 35: E28.
30. Suri DL, Tomlanovich SJ, Olson JL, Meyer TW. Transplant glomerulopathy as a cause of late graft loss. Am J Kidney Dis 2000; 35: 674-680.
31. Racusen LC, Solez K, Colvin RB et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999; 55: 713-723.
32. Collins AB, Schneeberger EE, Pascual MA et al. Complement activation in acute humoral renal allograft rejection: diagnostic significance of C4d deposits in peritubular capillaries. J Am Soc Nephrol 1999; 10: 2208-2214.
33. Bricker NS, Morrin PAF, Kime SW Jr. The pathologic physiology of chronic Bright's disease. An exposition of the 'intact nephron hypothesis'. J Am Soc Nephrol 1997; 8: 1470-1476.
34. Bonsib SM. Acute rejection-associated tubular basement membrane defects and chronic allograft nephropathy. Kidney Int 2000; 58: 2206-2214.
35. Nishi T, Bond C Jr, Brown G, Solez K, Heptinstall RH. A morphometric study of arterial intimal thickening in kidneys of dialyzed patients. Am J Pathol 1979; 95: 597-610.
36. Trpkov K, Campbell P, Pazderka F, Cockfield S, Solez K, Halloran PF. Pathologic features of acute renal allograft rejection associated with donor-specific antibody. Transplant 1996; 61: 1586-1592.
37. Bromley SK, Burack WR, Johnson KG et al. The immunological synapse. Annu Rev Immunol 2001; 19: 375-396.
38. Baker RJ, Hernandez-Fuentes MP, Brookes PA, Chaudhry AN, Cook HT, Lechler RI. Loss of direct and maintenance of indirect alloresponses in renal allograft recipients: implications for the pathogenesis of chronic allograft nephropathy. J Immunol 2001; 167: 7199-7206.
39. SivaSai KS, Smith MA, Poindexter NJ et al. Indirect recognition of donor HLA class I peptides in lung transplant recipients with bronchiolitis obliterans syndrome. Transplant 1999; 67: 1094-1098.
40. Jaramillo A, Smith MA, Phelan D et al. Development of ELISA-detected anti-HLA antibodies precedes the development of bronchiolitis obliterans syndrome and correlates with progressive decline in pulmonary function after lung transplantation. Transplant 1999; 67: 1155-1161.
41. Vella JP, Spadafora-Ferreira M, Murphy B et al. Indirect allorecognition of major histocompatibility complex allopeptides in human renal transplant recipients with chronic graft dysfunction. Transplant 1997; 64: 795-800.
42. Vella JP, Vos L, Carpenter CB, Sayegh MH. Role of indirect allorecognition in experimental late acute rejection. Transplant 1997; 64: 1823-1828.
43. Liu Z, Colovai AI, Tugulea S et al. Indirect recognition of donor HLA-DR peptides in organ allograft rejection. J Clin Invest 1996; 98: 1150-1157.
44. Molajoni ER, Cinti P, Orlandini A et al. Mechanism of liver allograft rejection: the indirect recognition pathway. Hum Immunol 1997; 53: 57-63.
45. Ciubotariu R, Liu Z, Colovai AI et al. Persistent allopeptide reactivity and epitope spreading in chronic rejection of organ allografts. J Clin Invest 1998; 101: 398-405.
46. Hornick PI, Mason PD, Baker RJ et al. Significant frequencies of T cells with indirect anti-donor specificity in heart graft recipients with chronic rejection. Circulation 2000; 101: 2405-2410.
47. Hornick PI, Mason PD, Yacoub MH, Rose ML, Batchelor R, Lechler RI. Assessment of the contribution that direct allorecognition makes to the progression of chronic cardiac transplant rejection in humans. Circulation 1998; 97: 1257-1263.